Phantom Superbug in Middle East Could Spread Worldwide

By Petrina Smith
Monday, 02 June, 2014


Phantom Superbug in Middle East Could Spread Worldwide

Researcher Hosam Mamoon Zowawi said the ‘phantom’ superbugs were found during a region-wide collaborative study on superbugs.A phantom superbug  in the Middle East is cloaking itself in genetic material to avoid detection and placing the population at increased risk of deadly infections.
University of Queensland Researchers who discovered the n antibiotic-resistant bacteria warn the hard-to-detect superbugs may quickly spread beyond the region and emerge worldwide.
Researcher Hosam Mamoon Zowawi (pictured right), from the UQ Centre for Clinical Research, said the ‘phantom’ superbugs were found during a region-wide collaborative study on superbugs in the Gulf Cooperation Council (GCC) states of Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman and Bahrain.
“The study found antibiotic-resistant bacteria in samples from all GCC states,” Mr Zowawi said.
“Not only were the bacteria widespread, but they were found to be carrying genetic material which empowers them to resist antibiotics and avoid detection in routine laboratory testing.
“This means patients are not being treated quickly with the right antibiotics, allowing the bacteria time to spread.
“The results of this study will hopefully encourage laboratories to introduce more specific testing techniques to identify and prevent overlooking the presence of phantom superbugs.
“Implementing effective infection control precautions is also essential to minimise the spread of superbugs.
“Several clusters of the phantom superbugs were also detected in different patients from the same hospitals, suggesting patient-to-patient spread of infection is occurring,” Mr Zowawi said.
The research team is now developing new diagnostic techniques to rapidly identify antibiotic-resistant bacteria, including the phantom superbug.
“We hope this will help in advancing the surveillance of superbugs by reducing the turnaround time to identify the deadly bacteria,” Mr Zowawi said.
“It will also assist clinicians to apply targeted treatment and implement infection control precautions sooner.”
The research findings are published in this month's Antimicrobials Agents and Chemotherapy journal

Related Articles

Losing our minds — an AU$85bn phenomenon

There is a storm brewing, largely unnoticed: the convergence of two high-prevalence, high-impact...

Upholding a new model of mental health care

The Ipswich Hospital Mental Health Acute Inpatient Service was recently recognised at the...

Enhancing hearing loss diagnostics and outcomes in primary care

Hearing health is integral to overall physical and emotional wellbeing, yet it often remains...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd